BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35233113)

  • 21. Ghana's COVID-19 response: the Black Star can do even better.
    Quakyi NK; Agyemang Asante NA; Nartey YA; Bediako Y; Sam-Agudu NA
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33712435
    [No Abstract]   [Full Text] [Related]  

  • 22. Integration of multiple geospatial applications and intelligence for responding to COVID-19 in Ghana.
    Owusu AB; Afagbedzi SK; Bandoh DA; Frimpong JA; Kissiedu IN; Aikins BE; Hinneh R; Kenu E
    Ghana Med J; 2021 Jun; 55(2 Suppl):10-20. PubMed ID: 35233110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview.
    Boschiero MN; Palamim CVC; Ortega MM; Mauch RM; Marson FAL
    Ann Glob Health; 2021 May; 87(1):44. PubMed ID: 34046307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a community-based COVID-19 intervention in rural Ghana: a document analysis.
    Frimpong SO; Seidu M; Hilton SK; Ransome Y; Paintsil E; Talbert-Slagle K; Dorcoo-Attipoe S; Brayne C
    BMC Public Health; 2022 Oct; 22(1):1920. PubMed ID: 36242031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 hot-spot strategy: a special innovation in pandemic response, Oyo State Nigeria.
    Bassey EB; Kazadi Mulomb W; Ahmed Khedr AM; Mpazanje RG; Onyibe RI; Kolude OO; Marcus O; Alawale O; Ogunlaja O; Oluwatobi AI; Adedamola AT; Olayiwola SO; Ladipo TO
    BMC Public Health; 2022 Feb; 22(1):233. PubMed ID: 35120487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost of clinical management of SARS-COV-2 (COVID-19) infection by level of disease severity in Ghana: a protocol-based cost of illness analysis.
    Ismaila H; Asamani JA; Lokossou VK; Oduro-Mensah E; Nabyonga-Orem J; Akoriyea SK
    BMC Health Serv Res; 2021 Oct; 21(1):1115. PubMed ID: 34663308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards effective participation of the private health sector in Ghana's COVID-19 response.
    Nimako BA; Baiden F; Awoonor-Williams JK
    Pan Afr Med J; 2020; 35(Suppl 2):47. PubMed ID: 33623572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 in Saudi Arabia: the national health response.
    Khan A; Alsofayan Y; Alahmari A; Alowais J; Algwizani A; Alserehi H; Assiri A; Jokhdar H
    East Mediterr Health J; 2021 Dec; 27(11):1114-1124. PubMed ID: 34927716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sociodemographic and clinical characteristics of the first cohort of COVID-19 recoveries at two national treatment centres in Accra, Ghana.
    Owoo C; Oliver-Commey JA; Calys-Tagoe BNL; Oduro-Mensah E; Ofori-Boadu L; Adjei-Mensah E; Kenu E; Samba A; Yawson AE; Lartey M;
    Ghana Med J; 2020 Dec; 54(4 Suppl):16-22. PubMed ID: 33976437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interrupting the chains of transmission of COVID-19 in Italy: survey among the Prevention Departments].
    Salmaso S; Zambri F; Renzi M; Giusti A
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):33-41. PubMed ID: 33412792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection prevention and control compliance among exposed healthcare workers in COVID-19 treatment centers in Ghana: A descriptive cross-sectional study.
    Ashinyo ME; Dubik SD; Duti V; Amegah KE; Ashinyo A; Asare BA; Ackon AA; Akoriyea SK; Kuma-Aboagye P
    PLoS One; 2021; 16(3):e0248282. PubMed ID: 33690699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electronic reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID-19 in Denmark.
    Schønning K; Dessau RB; Jensen TG; Thorsen NM; Wiuff C; Nielsen L; Gubbels S; Denwood M; Thygesen UH; Christensen LE; Møller CH; Møller JK; Ellermann-Eriksen S; Østergaard C; Lam JUH; Abushalleeh N; Meaidi M; Olsen S; Mølbak K; Voldstedlund M
    APMIS; 2021 Jul; 129(7):438-451. PubMed ID: 33949007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of Ghana's 2009-2013 integrated strategic response plan for pandemic influenza: illustrative study of the perceived adequacy of preparedness for the pandemic influenza of sub-Sahara Africa.
    Norman ID; Aikins MK; Binka FN; Godi AH
    Emerg Med J; 2013 May; 30(5):388-92. PubMed ID: 22843551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strengthening health system building blocks: configuring post-COVID-19 scenario in Pakistan.
    Shaikh BT
    Prim Health Care Res Dev; 2021 Mar; 22():e9. PubMed ID: 33762035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparedness and Responses Faced during the COVID-19 Pandemic in Belgium: An Observational Study and Using the National Open Data.
    He R; Zhang J; Mao Y; Degomme O; Zhang WH
    Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33143076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One year after first case of COVID-19 in Ghana: epidemiology, challenges and accomplishments.
    Amponsah SK; Tagoe B; Afriyie DK
    Pan Afr Med J; 2021; 39():226. PubMed ID: 34630838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge into the Practice against COVID-19: A Cross-Sectional Study from Ghana.
    Yeboah P; Daliri DB; Abdin AY; Appiah-Brempong E; Pitsch W; Panyin AB; Adusei EBA; Razouk A; Nasim MJ; Jacob C
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
    Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.